Compare Abeona Therapeutics Inc (ABEO) vs Advanced Micro Devices (AMD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Advanced Micro Devices — how do they compare? Abeona Therapeutics Inc trades at $6.68 (market cap $373.32M), while Advanced Micro Devices trades at $510.17 (market cap $841.57B). The key difference: Advanced Micro Devices is far larger — about 2254.3× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | AMD | |
|---|---|---|
Market Cap | $373.32M | $841.57B |
Sector | Health | Technology |
52-Week High | $7.23 | $580.91 |
52-Week Low | $4.17 | $137.82 |
Enterprise Value | $228.22M | $833.09B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
AMD trades at $552.05, up 6.61% today and near its 52-week high, with strong technical momentum and bullish moving averages. The company reported robust Q1 2026 earnings of $1.37 EPS, beating expectations, and shows accelerating revenue growth to $34.64 billion in 2025 with net income surging to $4.34 billion. Analyst sentiment remains overwhelmingly positive with 71% buy ratings.
AMD's AI-driven growth trajectory presents significant upside potential, though premium valuations (P/E 184) and intense semiconductor competition pose risks. The stock's technical strength and fundamental momentum support continued bullish sentiment, but investors should monitor execution against high expectations and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Advanced Micro Devices
Advanced Micro Devices, Inc. (AMD) produces semiconductor products and devices. The Company offers products such as microprocessors, embedded microprocessors, chipsets, graphics, video and multimedia products and supplies it to third-party foundries, as well as provides assembling, testing, and packaging services. AMD serves customers worldwide.
Read more on AMD →
